Search research articles
Contact Us
Filters
Showing results (61-70 of 325) with videos related to
Page
of 33
Sort By:
Neurology
|
March 1, 1984
HLA-linked complement markers in Alzheimer's and Parkinson's disease: C4 variant (C4B2) a possible marker for senile dementia of the Alzheimer type
C Nerl, R Mayeux, G J O'Neill
Neurology
|
June 1, 1981
Depression, intellectual impairment, and Parkinson disease
R Mayeux, Y Stern, J Rosen, et al.
The Journal of Nutrition, Health & Aging
|
May 18, 2007
Glycemic load and risk of Alzheimer's disease
J A Luchsinger, M X Tang, R Mayeux
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1994
Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination
M Richards, K Marder, L Cote, et al.
Archives of Neurology
|
October 1, 1993
Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease
Y Stern, M Richards, M Sano, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1990
A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease
M Sano, Y Stern, K Marder, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 1, 1988
Prism adaptation in Parkinson's disease
Y Stern, R Mayeux, A Hermann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 1, 1994
Reliability of symptom onset assessment in Parkinson's disease
M Richards, K Marder, L Cote, et al.
Biochemical Pharmacology
|
May 16, 2000
Role of nitric oxide in lipopolysaccharide-induced oxidant stress in the rat kidney
C Zhang, L M Walker, P R Mayeux
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1983
Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement
Y Stern, R Mayeux, J Rosen, et al.
Page
of 33
Search research articles
Search
Showing results (61-70 of 325) with videos related to
Sort By:
Page
of 33
Neurology
|
March 1, 1984
HLA-linked complement markers in Alzheimer's and Parkinson's disease: C4 variant (C4B2) a possible marker for senile dementia of the Alzheimer type
C Nerl, R Mayeux, G J O'Neill
Neurology
|
June 1, 1981
Depression, intellectual impairment, and Parkinson disease
R Mayeux, Y Stern, J Rosen, et al.
The Journal of Nutrition, Health & Aging
|
May 18, 2007
Glycemic load and risk of Alzheimer's disease
J A Luchsinger, M X Tang, R Mayeux
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1994
Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination
M Richards, K Marder, L Cote, et al.
Archives of Neurology
|
October 1, 1993
Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease
Y Stern, M Richards, M Sano, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 1, 1990
A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease
M Sano, Y Stern, K Marder, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 1, 1988
Prism adaptation in Parkinson's disease
Y Stern, R Mayeux, A Hermann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 1, 1994
Reliability of symptom onset assessment in Parkinson's disease
M Richards, K Marder, L Cote, et al.
Biochemical Pharmacology
|
May 16, 2000
Role of nitric oxide in lipopolysaccharide-induced oxidant stress in the rat kidney
C Zhang, L M Walker, P R Mayeux
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1983
Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement
Y Stern, R Mayeux, J Rosen, et al.
Page
of 33